Two professors at The University of Texas Health Science Center at Houston (UTHealth) Barry Davis, M.D., Ph.D., and Kevin Morano, Ph.D. have been elected fellows into the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.
Davis is recognized for his leadership to advance public health and his contributions to clinical trials especially in high blood pressure and Morano for his investigations into mechanisms underlying Alzheimer's disease and other conditions.
Davis and Morano were among 388 AAAS members awarded this honor in 2013 and will be recognized on Feb. 15 at the 2014 AAAS Annual Meeting in Chicago. Elected by their AAAS peers, fellows are chosen based on their scientifically or socially distinguished efforts to advance science or its applications.
"UTHealth is proud of this national recognition for two of our exceptional scientists. This is a well-deserved honor for Drs. Morano and Davis and speaks to the caliber of science at UTHealth," said UTHealth President Giuseppe Colasurdo, M.D.
Davis, a biostatistician, led a landmark study of blood pressure medications, which found that diuretics or water pills matched or outperformed higher priced medications. More than 42,000 people participated in the study called the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT findings were confirmed in follow-up studies demonstrating that diuretics remain unsurpassed when it comes to reducing high blood pressure and preventing major complications.
Davis is the holder of the Guy S. Parcel Chair in Public Health and director of the Coordinating Center for Clinical Trials at The University of Texas School of Public Health, part of UTHealth. He received his medical degree at University of California, San Diego and his doctorate degree at Brown University.
"I am gra
|Contact: Robert Cahill|
University of Texas Health Science Center at Houston